Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
The current price of ABTT34.SA is R$44 BRL — it has increased by +0.59% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
What is Abbott Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Abbott Laboratories stocks are traded under the ticker ABTT34.SA.
Is Abbott Laboratories stock price growing?▼
ABTT34.SA stock has fallen by -0.56% compared to the previous week, the month change is a -6.38% fall, over the last year Abbott Laboratories has showed a -27.96% decrease.
What is Abbott Laboratories market cap?▼
Today Abbott Laboratories has the market capitalization of 76.46B
When is the next Abbott Laboratories earnings date?▼
Abbott Laboratories is going to release the next earnings report on April 16, 2026.
What were Abbott Laboratories earnings last quarter?▼
ABTT34.SA earnings for the last quarter are 7.93 BRL per share, whereas the estimation was 7.9 BRL resulting in a +0.29% surprise. The estimated earnings for the next quarter are N/A BRL per share.
What is Abbott Laboratories revenue for the last year?▼
Abbott Laboratories revenue for the last year amounts to 487.61B BRL.
What is Abbott Laboratories net income for the last year?▼
ABTT34.SA net income for the last year is 71.72B BRL.
Does Abbott Laboratories pay dividends?▼
Yes, ABTT34.SA dividends are paid quarterly. The last dividend per share was 0.19 BRL. As of today, Dividend Yield (FWD)% is 29.51%.
How many employees does Abbott Laboratories have?▼
As of April 08, 2026, the company has 113,000 employees.
In which sector is Abbott Laboratories located?▼
Abbott Laboratories operates in the Healthcare sector.
When did Abbott Laboratories complete a stock split?▼
The last stock split for Abbott Laboratories was on November 21, 2022 with a ratio of 3:1.
Where is Abbott Laboratories headquartered?▼
Abbott Laboratories is headquartered in North Chicago, United States.